Alyeska Investment Group, L.P. Bellus Health Inc. Transaction History

Alyeska Investment Group, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.46 - $10.02 $398,775 - $618,534	-61,730 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.56 - $7.99 $73,781 - $106,027	-13,270 Reduced 17.69%	61,730 $425,000
Q4 2021 Feb 14, 2022	BUY	$5.26 - $8.3 $23,585 - $37,217	4,484 Added 6.36%	75,000 $604,000
Q4 2019 Feb 14, 2020	BUY	$5.76 - $7.6 $1,543 - $2,036	268 Added 0.38%	70,516 $535,000
Q3 2019 Nov 14, 2019	BUY	$6.24 - $8.84 $438,347 - $620,992	70,248 New	70,248 $448,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.